Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses

ABSTRACT The HIV-1 accessory protein Vpu enhances viral release by counteracting the restriction factor BST-2. Furthermore, Vpu promotes NK cell evasion by downmodulating cell surface NTB-A and PVR, known ligands of the NK cell receptors NTB-A and DNAM-1, respectively. While it has been established...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jérémie Prévost, Suzanne Pickering, Mitchell J. Mumby, Halima Medjahed, Gabrielle Gendron-Lepage, Gloria G. Delgado, Brennan S. Dirk, Jimmy D. Dikeakos, Christina M. Stürzel, Daniel Sauter, Frank Kirchhoff, Frederic Bibollet-Ruche, Beatrice H. Hahn, Mathieu Dubé, Daniel E. Kaufmann, Stuart J. D. Neil, Andrés Finzi, Jonathan Richard
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
HIV
PVR
Acceso en línea:https://doaj.org/article/a9c7f1cd222240a497b7cabeef046a5f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9c7f1cd222240a497b7cabeef046a5f
record_format dspace
spelling oai:doaj.org-article:a9c7f1cd222240a497b7cabeef046a5f2021-11-15T15:55:25ZUpregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses10.1128/mBio.01113-192150-7511https://doaj.org/article/a9c7f1cd222240a497b7cabeef046a5f2019-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01113-19https://doaj.org/toc/2150-7511ABSTRACT The HIV-1 accessory protein Vpu enhances viral release by counteracting the restriction factor BST-2. Furthermore, Vpu promotes NK cell evasion by downmodulating cell surface NTB-A and PVR, known ligands of the NK cell receptors NTB-A and DNAM-1, respectively. While it has been established that Vpu’s transmembrane domain (TMD) is required for the interaction and intracellular sequestration of BST-2, NTB-A, and PVR, it remains unclear how Vpu manages to target these proteins simultaneously. In this study, we show that upon upregulation, BST-2 is preferentially downregulated by Vpu over its other TMD substrates. We found that type I interferon (IFN)-mediated BST-2 upregulation greatly impairs the ability of Vpu to downregulate NTB-A and PVR. Our results suggest that occupation of Vpu by BST-2 affects its ability to downregulate other TMD substrates. Accordingly, knockdown of BST-2 increases Vpu’s potency to downmodulate NTB-A and PVR in the presence of type I IFN treatment. Moreover, we show that expression of human BST-2, but not that of the macaque orthologue, decreases Vpu’s capacity to downregulate NTB-A. Importantly, we show that type I IFNs efficiently sensitize HIV-1-infected cells to NTB-A- and DNAM-1-mediated direct and antibody-dependent NK cell responses. Altogether, our results reveal that type I IFNs decrease Vpu’s polyfunctionality, thus reducing its capacity to protect HIV-1-infected cells from NK cell responses. IMPORTANCE The restriction factor BST-2 and the NK cell ligands NTB-A and PVR are among a growing list of membrane proteins found to be downregulated by HIV-1 Vpu. BST-2 antagonism enhances viral release, while NTB-A and PVR downmodulation contributes to NK cell evasion. However, it remains unclear how Vpu can target multiple cellular factors simultaneously. Here we provide evidence that under physiological conditions, BST-2 is preferentially targeted by Vpu over NTB-A and PVR. Specifically, we show that type I IFNs decrease Vpu’s polyfunctionality by upregulating BST-2, thus reducing its capacity to protect HIV-1-infected cells from NK cell responses. This indicates that there is a hierarchy of Vpu substrates upon IFN treatment, revealing that for the virus, targeting BST-2 as part of its resistance to IFN takes precedence over evading NK cell responses. This reveals a potential weakness in HIV-1’s immunoevasion mechanisms that may be exploited therapeutically to harness NK cell responses against HIV-1.Jérémie PrévostSuzanne PickeringMitchell J. MumbyHalima MedjahedGabrielle Gendron-LepageGloria G. DelgadoBrennan S. DirkJimmy D. DikeakosChristina M. StürzelDaniel SauterFrank KirchhoffFrederic Bibollet-RucheBeatrice H. HahnMathieu DubéDaniel E. KaufmannStuart J. D. NeilAndrés FinziJonathan RichardAmerican Society for MicrobiologyarticleADCCDNAM-1HIVNK cellsNTB-APVRMicrobiologyQR1-502ENmBio, Vol 10, Iss 3 (2019)
institution DOAJ
collection DOAJ
language EN
topic ADCC
DNAM-1
HIV
NK cells
NTB-A
PVR
Microbiology
QR1-502
spellingShingle ADCC
DNAM-1
HIV
NK cells
NTB-A
PVR
Microbiology
QR1-502
Jérémie Prévost
Suzanne Pickering
Mitchell J. Mumby
Halima Medjahed
Gabrielle Gendron-Lepage
Gloria G. Delgado
Brennan S. Dirk
Jimmy D. Dikeakos
Christina M. Stürzel
Daniel Sauter
Frank Kirchhoff
Frederic Bibollet-Ruche
Beatrice H. Hahn
Mathieu Dubé
Daniel E. Kaufmann
Stuart J. D. Neil
Andrés Finzi
Jonathan Richard
Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
description ABSTRACT The HIV-1 accessory protein Vpu enhances viral release by counteracting the restriction factor BST-2. Furthermore, Vpu promotes NK cell evasion by downmodulating cell surface NTB-A and PVR, known ligands of the NK cell receptors NTB-A and DNAM-1, respectively. While it has been established that Vpu’s transmembrane domain (TMD) is required for the interaction and intracellular sequestration of BST-2, NTB-A, and PVR, it remains unclear how Vpu manages to target these proteins simultaneously. In this study, we show that upon upregulation, BST-2 is preferentially downregulated by Vpu over its other TMD substrates. We found that type I interferon (IFN)-mediated BST-2 upregulation greatly impairs the ability of Vpu to downregulate NTB-A and PVR. Our results suggest that occupation of Vpu by BST-2 affects its ability to downregulate other TMD substrates. Accordingly, knockdown of BST-2 increases Vpu’s potency to downmodulate NTB-A and PVR in the presence of type I IFN treatment. Moreover, we show that expression of human BST-2, but not that of the macaque orthologue, decreases Vpu’s capacity to downregulate NTB-A. Importantly, we show that type I IFNs efficiently sensitize HIV-1-infected cells to NTB-A- and DNAM-1-mediated direct and antibody-dependent NK cell responses. Altogether, our results reveal that type I IFNs decrease Vpu’s polyfunctionality, thus reducing its capacity to protect HIV-1-infected cells from NK cell responses. IMPORTANCE The restriction factor BST-2 and the NK cell ligands NTB-A and PVR are among a growing list of membrane proteins found to be downregulated by HIV-1 Vpu. BST-2 antagonism enhances viral release, while NTB-A and PVR downmodulation contributes to NK cell evasion. However, it remains unclear how Vpu can target multiple cellular factors simultaneously. Here we provide evidence that under physiological conditions, BST-2 is preferentially targeted by Vpu over NTB-A and PVR. Specifically, we show that type I IFNs decrease Vpu’s polyfunctionality by upregulating BST-2, thus reducing its capacity to protect HIV-1-infected cells from NK cell responses. This indicates that there is a hierarchy of Vpu substrates upon IFN treatment, revealing that for the virus, targeting BST-2 as part of its resistance to IFN takes precedence over evading NK cell responses. This reveals a potential weakness in HIV-1’s immunoevasion mechanisms that may be exploited therapeutically to harness NK cell responses against HIV-1.
format article
author Jérémie Prévost
Suzanne Pickering
Mitchell J. Mumby
Halima Medjahed
Gabrielle Gendron-Lepage
Gloria G. Delgado
Brennan S. Dirk
Jimmy D. Dikeakos
Christina M. Stürzel
Daniel Sauter
Frank Kirchhoff
Frederic Bibollet-Ruche
Beatrice H. Hahn
Mathieu Dubé
Daniel E. Kaufmann
Stuart J. D. Neil
Andrés Finzi
Jonathan Richard
author_facet Jérémie Prévost
Suzanne Pickering
Mitchell J. Mumby
Halima Medjahed
Gabrielle Gendron-Lepage
Gloria G. Delgado
Brennan S. Dirk
Jimmy D. Dikeakos
Christina M. Stürzel
Daniel Sauter
Frank Kirchhoff
Frederic Bibollet-Ruche
Beatrice H. Hahn
Mathieu Dubé
Daniel E. Kaufmann
Stuart J. D. Neil
Andrés Finzi
Jonathan Richard
author_sort Jérémie Prévost
title Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
title_short Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
title_full Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
title_fullStr Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
title_full_unstemmed Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
title_sort upregulation of bst-2 by type i interferons reduces the capacity of vpu to protect hiv-1-infected cells from nk cell responses
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/a9c7f1cd222240a497b7cabeef046a5f
work_keys_str_mv AT jeremieprevost upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT suzannepickering upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT mitchelljmumby upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT halimamedjahed upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT gabriellegendronlepage upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT gloriagdelgado upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT brennansdirk upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT jimmyddikeakos upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT christinamsturzel upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT danielsauter upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT frankkirchhoff upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT fredericbibolletruche upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT beatricehhahn upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT mathieudube upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT danielekaufmann upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT stuartjdneil upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT andresfinzi upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
AT jonathanrichard upregulationofbst2bytypeiinterferonsreducesthecapacityofvputoprotecthiv1infectedcellsfromnkcellresponses
_version_ 1718427168301645824